Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2006; 12(5): 739-746
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.739
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.739
Table 2 Microproteinuria and creatinine clearance in active and inactive IBD (mean±SE)
| Ulcerative colitis (n = 194) | Crohn's disease (n = 83) | |||||
| Active(n=49) | Inactive(n=145) | P | Active(n=15) | Inactive(n=68) | P | |
| Urine m-ALB (μg/min) | 11.89 ± 3.19 | 9.0 ± 1.03 | NS | 8.59 ± 2.65 | 7.02 ± 1.07 | NS |
| Urine β2mGLB (μg/min) | 204 ± 50.2 | 88.0 ± 10.28 | <0.01 | 359 ± 130.9 | 92.2 ± 16.26 | <0.05 |
| Urine β-NAG (U/L) | 4.69 ± 0.64 | 2.39 ± 0.16 | <0.001 | 3.07 ± 0.90 | 2.36 ± 0.25 | NS |
| Urine Kcr (mL/min) | 114.4 ± 6.03 | 120.3 ± 3.24 | NS | 135.6 ± 8.34 | 127.7 ± 3.96 | NS |
- Citation: Poulou AC, Goumas KE, Dandakis DC, Tyrmpas I, Panagiotaki M, Georgouli A, Soutos DC, Archimandritis A. Microproteinuria in patients with inflammatory bowel disease: Is it associated with the disease activity or the treatment with 5-aminosalicylic acid? World J Gastroenterol 2006; 12(5): 739-746
- URL: https://www.wjgnet.com/1007-9327/full/v12/i5/739.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i5.739